Home » Sophie Kinsella, ‘I have brain cancer, I’m having chemo’ – Focus Tumor news

Sophie Kinsella, ‘I have brain cancer, I’m having chemo’ – Focus Tumor news

by admin
Sophie Kinsella, ‘I have brain cancer, I’m having chemo’ – Focus Tumor news

The English writer Sophie Kinsella has brain cancer, has undergone surgery and is undergoing radiotherapy and chemotherapy. She announced it herself with a message on social media.
“I have wanted to share a health update with you for a long time – writes the author of many best sellers – and I was waiting for the strength to do so. At the end of 2022 I was diagnosed with glioblastoma, a form of aggressive brain cancer. I didn’t share this before because I wanted to make sure my children were able to hear and process the news in privacy and adjust to our new normal.” Kinsella also addresses all those suffering from cancer in any form: “To them I send love and best wishes, as well as to those who support them. Having a difficult diagnosis can make you feel very alone and scared and the support and care of Those around you mean more than words can say.”


In 2022, according to data from the Italian Association of Medical Oncology (Aiom), approximately 6,300 new diagnoses were estimated. Estimates for 2023 are not available. There are 52,800 people living in Italy after a diagnosis of central nervous system (CNS) tumor. These neoplasms are made up of a group of entities that are heterogeneous in terms of morphology, site of onset, biological, clinical and prognostic aspects.
Among the risk factors, exposures to gamma and X radiation are defined by IARC as Group 1 carcinogens for CNS tumors; for exposure to electromagnetic fields, however, limited evidence is recognized in humans.
Some genetic syndromes are associated with an increased development of CNS tumors, for example neurofibromatoses and Li-Fraumeni syndrome.
Furthermore, an increased familial risk not associated with known genetic syndromes was observed. Unlike some industrialized countries such as the USA and England where there is a constant increase, the incidence of CNS tumors in Italy appears more or less stable in recent years; Malignant tumors are more frequent in men than in women.
There is no possibility of “early diagnosis”. Most CNS tumors are diagnosed following the appearance of symptoms. Until now, no effective population-level tests for early diagnosis are recognized.
As regards primary prevention, some recent epidemiological studies have excluded the role of mobile phones but while waiting for confirmatory studies, the American Cancer Society suggests that those who have concerns about this exposure limit their use, especially to children, and to use earphones.
The most frequent malignant tumor of the CNS in adults is glioblastoma, with an estimated incidence rate of around 3-4 cases per 100 thousand inhabitants per year. The average age of onset of glioblastoma is around 65 years. Standard therapy consists of surgical resection followed by radiotherapy and chemotherapy. A phase 3 study also highlighted the association of a device that emits electric fields (TTFields) with standard therapy as promising. There are also first positive results for “targeted therapy” in brain tumors. Due to the rarity of the tumor pathology and specific genetic mutations, it is essential, when possible, to take care of and include patients in protocols trials at reference neuro-oncology centers.

See also  Ipsos, Italy is less happy than the rest of the world - breaking latest news

breaking latest news © Copyright ANSA

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy